Streetbeat News

ETRGF

Entourage Health Corp

CEO

Angelo Tsebelis

Industry

Medicinal and Botanical Manufacturing

Open

0.01

Mkt cap

2.3M

Volume

5K

High

0.01

P/E Ratio

-0.07

52-wk high

0.01

Low

0.01

Div yield

N/A

52-wk low

0.00

Entourage Health Corp. (OTCPK:ETRGF) held its Q3 2024 earnings conference call on November 29, 2024. Key participants included Catherine Flaman, George Scorsis, and Vaani Maharaj.

Portfolio Pulse from

November 29, 2024 | 4:30 pm

Entourage Health Corp. reported strong financial results for Q3 2024, highlighting its performance in the cannabis sector. The company will discuss these results in a conference call.

Portfolio Pulse from

November 29, 2024 | 1:00 pm

Entourage Health Corp., a Canadian cannabis company, will release its Q3 2024 financial results on November 28, 2024, and host a conference call on November 29, 2024, to discuss the results and provide an operational update.

Portfolio Pulse from

November 21, 2024 | 12:45 pm

Entourage Health Corp. reported a nearly 9% YoY drop in Q2 revenue, with a net loss of CA$10.3 million. Despite the decline, the company is optimistic about future opportunities, focusing on expanding distribution and strategic partnerships.

Portfolio Pulse from Jelena Martinovic

August 27, 2024 | 1:37 pm

Several cannabis companies, including IM Cannabis, cbdMD, Entourage Health, and Organigram Holdings, are set to report their earnings for the second quarter of 2024. IM Cannabis will discuss its results and recent share consolidation plan, cbdMD will address its operational losses and cost-cutting measures, Entourage Health will provide an update on its financial health, and Organigram Holdings will report its earnings and discuss its strategic investments in the European market.

Portfolio Pulse from Jelena Martinovic

August 06, 2024 | 5:22 pm

Recent leadership changes in the cannabis and psychedelics industries include new board members and executives at Cybin Inc., Curaleaf Holdings, Planet 13 Holdings, Charlotte’s Web Holdings, Flora Corporation, Entourage Health Corp., and TILT Holdings. These changes could impact the strategic direction and performance of these companies.

Portfolio Pulse from Jelena Martinovic

June 18, 2024 | 4:48 am

Entourage Health Corp. reported a 9% YoY increase in Q1 revenue, positive EBITDA, and substantial growth. The company achieved a gross profit of CA$5.8 million and a gross margin of 45%. Despite a loss of CA$6.3 million, the company showed improved profitability and significant growth in its adult-use business.

Portfolio Pulse from Jelena Martinovic

May 28, 2024 | 12:42 pm

Entourage Health Corp. reported its fiscal year 2023 financial results, showing a slight decrease in net revenue to CA$40.7 million, but a significant 126% increase in gross profit and a 62.5% reduction in net loss. The company's EBITDA loss improved by 79% due to discontinuation of cultivation activities. Shares of Entourage traded 7.33% lower at $0.0091 per share.

Portfolio Pulse from Jelena Martinovic

April 30, 2024 | 3:25 pm

Nevada Governor Joe Lombardo appointed James Humm as the new leader of the state's Cannabis Compliance Board, succeeding Tyler Klimas. Klimas plans to start a consulting company after a cooling-off period. Humm previously worked at the Governor's Office of Economic Development. In other cannabis industry news, Mandesh Dosanjh became the executive board chair of the IRCC, Richard Drexler stepped down from Green Thumb Industries' board, and Philip Himmelstein was named interim CFO of Acreage Holdings, replacing Carl Nesbitt. Vincent Doré resigned from Entourage Health. The article also hints at potential growth in cannabis stocks, mentioning gains in Green Thumb Industries, Trulieve Cannabis, and Village Farms International.

Portfolio Pulse from Jelena Martinovic

December 11, 2023 | 5:16 pm

Entourage Health Corp. reported a decline in Q3 revenue by 8.8% YoY to CA$12.2 million, but saw improvements in gross margins and reduced losses. The company's focus on operational efficiencies, automation, and cost reduction strategies contributed to a gross profit of CA$2.44 million compared to a gross loss last year, and a decrease in net loss to CA$9.9 million from CA$17.43 million. Despite a revenue decline, the company is positioning for sustained growth.

Portfolio Pulse from Nina Zdinjak

November 28, 2023 | 3:32 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.